Nano-ablative immunotherapy for cancer treatment
Immunotherapy has provided a new avenue to treat metastatic cancers, which result in ∼90% of cancer related deaths. However, current immunotherapies, such as immune checkpoint therapy (ICT), have met with limited success, primarily due to tumor intrinsic and extrinsic factors that inhibit antitumor...
Main Authors: | Hoover Ashley R., Liu Kaili, Valerio Trisha I., Li Min, Mukherjee Priyabrata, Chen Wei R. |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2021-08-01
|
Series: | Nanophotonics |
Subjects: | |
Online Access: | https://doi.org/10.1515/nanoph-2021-0171 |
Similar Items
-
Editorial: Overcoming obstacles of cancer immunotherapy: the important role of emerging nanomedicine
by: Aimin Jiang, et al.
Published: (2024-04-01) -
Balance and modulation of immunoediting for cancer treatment using synergistic nano-photo-immuno effects
by: Hoover Ashley R., et al.
Published: (2021-08-01) -
Contribution of immune cells in synergistic anti-tumor effect of ablation and immunotherapy
by: Ningning He, et al.
Published: (2024-02-01) -
Combinatory local ablation and immunotherapies for hepatocellular carcinoma: Rationale, efficacy, and perspective
by: Shuling Chen, et al.
Published: (2022-11-01) -
Nano Drug Delivery System for Tumor Immunotherapy: Next-Generation Therapeutics
by: Lili Zhou, et al.
Published: (2022-05-01)